PERSONENI, NICOLA
PERSONENI, NICOLA
Dipartimento di Biotecnologie Mediche e Medicina Traslazionale
A phase II randomized dose escalation trial of sorafenib in patients with advanced hepatocellular carcinoma
2013 L. Rimassa, T. Pressiani, C. Boni, C. Carnaghi, E. Rota Caremoli, S. Fagiuoli, P. Foa, S. Salvagni, E. Cortesi, M.C. Tronconi, N. Personeni, S. Bozzarelli, M.C. Banzi, S. Fanello, F. Romano Lutman, L. Giordano, A. Santoro
A randomized, multicenter, phase II study of vandetanib monotherapy versus vandetanib in combination with gemcitabine versus gemcitabine plus placebo in subjects with advanced biliary tract cancer : the VanGogh study
2015 A. Santoro, V. Gebbia, T. Pressiani, A. Testa, N. Personeni, E. Arrivas Bajardi, P. Foa, A. Buonadonna, K. Bencardino, C. Barone, D. Ferrari, A. Zaniboni, M.C. Tronconi, G. Carteni, M. Milella, A. Comandone, S. Ferrari, L. Rimassa
Achievements in systhemic therapies in the pre-genomic era in metastatic breast cancer
2007 C. M, A. E, N. Personeni, L. F, P. Mj, C. F.
Activity and safety of NGR-hTNF, a selective vascular-targeting agent, in previously treated patients with advanced hepatocellular carcinoma
2010 A. Santoro, T. Pressiani, G. Citterio, G. Rossoni, G. Donadoni, F. Pozzi, L. Rimassa, N. Personeni, S. Bozzarelli, G. Rossoni, S. Colombi, F.G. De Braud, F. Caligaris Cappio, A. Lambiase, C. Bordignon
Advanced colorectal liver metastases and surgery after preoperative chemotherapy : is response-based selection enough?
2011 N. Personeni, G. Torzilli, A. Santoro
ARQ 087, an oral pan- fibroblast growth factor receptor (FGFR) inhibitor, in patients (pts) with advanced and/or metastatic intrahepatic cholangiocarcinoma (iCCA)
2016 V.M. Mazzaferro, W. Shaib, L. Rimassa, W. Harris, N. Personeni, B. El-rayes, A. Tolcher, T. Hall, Y. Wang, B. Schwartz, J. Kazakin, M. DROZ DIT BUSSET, C. Cotsoglou, K. Papadopoulos
Assessment of HER2 status in patients with gastroesophageal adenocarcinoma treated with epirubicin-based chemotherapy: heterogeneity-related issues and prognostic implications
2016 N. Personeni, M. Baretti, S. Bozzarelli, P. Spaggiari, L. Rubino, M.C. Tronconi, U. Fumagalli Romario, R. Rosati, L. Giordano, M. Roncalli, A. Santoro, L. Rimassa
Biomarkers in hepatocellular carcinoma - Letter
2012 N. Personeni, L. Rimassa, A. Santoro
Can stereotactic body radiation therapy be a viable and efficient therapeutic option for unresectable locally advanced pancreatic adenocarcinoma? Results of a phase 2 study
2017 T. Comito, L. Cozzi, E. Clerici, C. Franzese, A. Tozzi, C. Iftode, P. Navarria, G. D'Agostino, L. Rimassa, C. Carnaghi, N. Personeni, M. Tronconi, F. De Rose, D. Franceschini, A. Ascolese, A. Fogliata, S. Tomatis, A. Santoro, A. Zerbi, M. Scorsetti
Clinical results of stereotactic body radiotherapy (SBRT) in the treatment of isolated local recurrence of pancreatic cancer after R0 surgery : a retrospective study
2017 T. Comito, L. Cozzi, A. Zerbi, C. Franzese, E. Clerici, A. Tozzi, C. Iftode, P. Navarria, G. D'Agostino, A. Fogliata, P. Mancosu, S. Tomatis, C. Carnaghi, N. Personeni, A. Santoro, M. Scorsetti
Clinical Usefulness of EGFR Gene Copy Number as a Predictive Marker in Colorectal Cancer Patients Treated with Cetuximab : A Fluorescent In situ Hybridization Study
2008 N. Personeni, S. Fieuws, H. Piessevaux, G. De Hertogh, J. De Schutter, B. Biesmans, W. De Roock, A. Capoen, M. Debiec Rychter, J. Van Laethem, M. Peeters, Y. Humblet, E. Van Cutsem, S. Tejpar
Correlation between the response to cetuximab alone or in combination with irinotecan and the activated/phosphorylated epidermal growth factor receptor in metastatic colorectal cancer
2005 N. Personeni, A. Hendlisz, A. Gallez, M. Gomez Galdon, D. Larsimont, J. Van Laethem, N. Nagy, M. Barette, M. Paesmans, F. Cardoso, H. Bleiberg
Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma.
2019 V. Mazzaferro, B. El-Rayes, M. Droz dit Busset, C. Cotsoglou, W. Harris, N. Damjanov, G. Masi, L. Rimassa, N. Personeni, F. Braiteh, V. Zagonel, K. Papadopoulos, T. Hall, Y. Wang, B. Schwartz, J. Kazakin, S. Bhoori, F. de Braud, W. Shaib
Diagnostic accuracy of 11C-choline PET/CT in comparison with CT and/or MRI in patients with hepatocellular carcinoma
2015 E. Lopci, G. Torzilli, D. Poretti, L.J..S. de Neto, M.D. Donadon, L. Rimassa, E. Lanza, J.G. Sabongi, R. Ceriani, N. Personeni, A. Palmisano, V. Pedicini, T. Comito, M. Scorsetti, A. Chiti
Epidermal growth factor receptor gene copy number in esophageal cancer and outcome prediction to gefitinib : does intratumoral heterogeneity matter?
2006 N. Personeni
Evaluation of HER-2/neu amplification and other biological markers as predictors of response to neoadjuvant anthracycline-based chemotherapy in primary breast cancer: the role of anthracycline dose intensity
2006 C. Bozzetti, A. Musolino, R. Camisa, G. Bisagn, M. Flora, C. Bassano, E. Martella, C. Lagrasta, R. Nizzoli, N. Personeni, F. Leonardi, G. Cocconi, A. Ardizzoni
Fatal Infusion Reaction to Cetuximab : The Need for Predictive Risk Factors and Safer Patient Selection
2011 M.C. Tronconi, F. Sclafani, L. Rimassa, C. Carnaghi, N. Personeni, A. Santoro
FOLFIRI and Cetuximab Every Second Week for First-Line Treatment of KRAS Wild-Type Metastatic Colorectal Cancer According to Phosphatase and Tensin Homolog Expression : a Phase II Study
2015 N. Personeni, L. Rimassa, C. Verusio, S. Barni, L. Rubino, S. Bozzarelli, E. Villa, C. Carnaghi, M.C. Tronconi, C. Gerardi, F. Galli, I. Floriani, A. Destro, C. Raschioni, R. Labianca, A. Santoro
Hepatic intra-arterial injection of Yttrium-loaded microspheres for liver metastasis secondary to colorectal cancer: best soups are sometimes made from old recipes
2006 A. Hendlisz, N. Personeni, T. Delaunoit, S. Debroux, P. Flamen
Hepatocellular Carcinoma : A Global Disease in Need of Individualized Treatment Strategies
2017 N. Personeni, L. Rimassa